课题基金 / 基金详情

Innate defenses against enterotoxigenic E. coli as potential therapeutic contributors

Innate defenses against enterotoxigenic E. coli as potential therapeutic contributors
针对产肠毒素大肠杆菌的先天防御作为潜在的治疗贡献者
批准号:
10745567
负责人:
Jennifer Foulke-Abel
金额:
$3.88万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-07-01 至 2026-06-30

项目摘要

项目成果

Jennifer Foulke-Abel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY The bacterial pathogen enterotoxigenic E. coli (ETEC) contributes to the global burden of diarrheal disease because vaccine protection and therapy remain inadequate. A long-term goal is to improve knowledge of innate immune responses to ETEC infection, as they are likely important for initiating durable adaptive immunity. The objective of this project is to understand the innate immune defenses employed by human intestine to sense and eliminate ETEC, thus informing strategies for vaccine and/or drug design. We will (Aim 1) characterize the recognition and response mechanisms employed by tissue resident macrophages and neutrophils against ETEC infection. In a complementary inquiry, we will (Aim 2) assess antimicrobial peptides (AMPs) released by epithelial and immune cells in response to ETEC that could serve as potential treatment. These aims will be explored in primary co-culture models of human small intestinal epithelium (tissue-derived enteroids) and immune cell types from peripheral blood that are assembled on scaffolds to facilitate physiologically relevant crosstalk between bacteria, epithelia, and immune cell populations. Model development, application of anaerobic environment to mimic conditions in the intestinal lumen, and characterization will combine the expertise of the Enteroid and Immunology Cores that support this P01. The proposed studies are significant in that they will indicate the molecular signal transduction involved in reacting to and resolving ETEC infection without clinically overt inflammation, an understudied aspect of acute pathogenic diarrheal disease. Results from these studies will be compared to findings from enteroaggregative E. coli and Shigella pathogenesis proposals in this P01 to identify common effectors for therapeutic targeting. The projects of this P01 will cumulatively innovate human primary epithelial and immune cell co-culture strategies for host-pathogen research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Human Enteroid Model of Cholera Toxin Pathophysiology
  • 批准号:
    10062959
  • 项目类别:
  • 资助金额:
    $15.82万
  • 财政年份:
    2018
  • 负责人:
    Jennifer Foulke-Abel
  • 依托单位:
A Human Enteroid Model of Cholera Toxin Pathophysiology
  • 批准号:
    10303063
  • 项目类别:
  • 资助金额:
    $15.82万
  • 财政年份:
    2018
  • 负责人:
    Jennifer Foulke-Abel
  • 依托单位:
Innate defenses against enterotoxigenic E. coli as potential therapeutic contributors
  • 批准号:
    10686839
  • 项目类别:
  • 资助金额:
    $46.14万
  • 财政年份:
    2016
  • 负责人:
    Jennifer Foulke-Abel
  • 依托单位:
Pathogenesis of E. coli and Shigella infections in human enteroid models
  • 批准号:
    10686819
  • 项目类别:
  • 资助金额:
    $213.92万
  • 财政年份:
    2016
  • 负责人:
    Jennifer Foulke-Abel
  • 依托单位:
海外基金